Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,663 | 21 | 75.6% |
| Food and Beverage | $5,146 | 198 | 15.8% |
| Consulting Fee | $1,433 | 2 | 4.4% |
| Travel and Lodging | $1,266 | 16 | 3.9% |
| Education | $135.76 | 11 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $10,907 | 31 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,979 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $6,460 | 18 | $0 (2017) |
| Lilly USA, LLC | $3,569 | 20 | $0 (2024) |
| Novo Nordisk Inc | $1,346 | 22 | $0 (2024) |
| Amgen Inc. | $468.09 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $330.96 | 11 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $269.63 | 2 | $0 (2019) |
| Insulet Corporation | $200.30 | 3 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $182.33 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $873.73 | 46 | Novo Nordisk Inc ($147.75) |
| 2023 | $1,005 | 46 | Amgen Inc. ($175.49) |
| 2022 | $1,944 | 36 | AstraZeneca Pharmaceuticals LP ($1,280) |
| 2021 | $2,681 | 10 | AstraZeneca Pharmaceuticals LP ($2,638) |
| 2020 | $7,296 | 20 | AstraZeneca Pharmaceuticals LP ($3,452) |
| 2019 | $11,840 | 65 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,919) |
| 2018 | $302.96 | 4 | Medtronic MiniMed, Inc. ($114.45) |
| 2017 | $6,699 | 21 | Janssen Pharmaceuticals, Inc ($6,460) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Durable Pump | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.07 | General |
| 11/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Endocrinology | ||||||
| 10/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.59 | General |
| 08/30/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/29/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Durable Pump | ||||||
| 08/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.11 | General |
| 08/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $6.27 | General |
| 08/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Bone Health | ||||||
| 07/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Endocrinology | ||||||
| 06/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/31/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/16/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,767 | 9,618 | $723,262 | $260,530 |
| 2022 | 23 | 3,009 | 12,192 | $886,261 | $317,745 |
| 2021 | 24 | 2,531 | 9,008 | $714,997 | $250,609 |
| 2020 | 30 | 2,364 | 7,563 | $670,568 | $207,246 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 63 | 5,881 | $274,760 | $108,280 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 626 | 1,022 | $267,764 | $87,059 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 79 | 95 | $33,535 | $11,748 | 35.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 117 | 122 | $34,282 | $9,502 | 27.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 230 | 276 | $12,696 | $8,007 | 63.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 257 | 343 | $8,918 | $5,646 | 63.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 114 | 212 | $18,868 | $5,352 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $16,800 | $5,016 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $14,112 | $3,895 | 27.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 257 | 369 | $11,070 | $3,496 | 31.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 258 | 344 | $4,816 | $3,032 | 63.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 226 | 291 | $10,185 | $3,007 | 29.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 83 | 93 | $2,139 | $1,375 | 64.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 83 | 101 | $2,121 | $1,325 | 62.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 66 | 123 | $6,027 | $1,207 | 20.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 99 | 119 | $1,428 | $897.98 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,124 | $626.58 | 29.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 41 | 44 | $924.00 | $587.84 | 63.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 24 | 30 | $390.00 | $248.70 | 63.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 47 | 52 | $208.00 | $164.38 | 79.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 16 | 19 | $95.00 | $59.09 | 62.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 84 | 8,042 | $375,722 | $137,949 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 686 | 1,177 | $308,374 | $102,287 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 93 | 100 | $35,300 | $12,709 | 36.0% |
| 82306 | Vitamin d-3 level | Office | 2022 | 247 | 312 | $14,352 | $9,125 | 63.6% |
About Dr. David Brantley, MD
Dr. David Brantley, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790706182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Brantley, MD has received a total of $32,643 in payments from pharmaceutical and medical device companies, with $873.73 received in 2024. These payments were reported across 248 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,663).
As a Medicare-enrolled provider, Brantley has provided services to 10,671 Medicare beneficiaries, totaling 38,381 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Charlotte, NC
- Active Since 07/21/2006
- Last Updated 01/23/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1790706182
Products in Payments
- FARXIGA (Drug) $10,892
- JARDIANCE (Drug) $10,297
- INVOKANA (Drug) $6,454
- Tresiba (Drug) $945.00
- EVENITY (Biological) $318.25
- t-slim insulin pump (Device) $269.63
- Omnipod (Device) $200.30
- Ozempic (Drug) $186.98
- Kerendia (Drug) $182.33
- TOUJEO (Drug) $138.48
- UNITHROID (Drug) $134.32
- Minimed 670G System (Device) $131.29
- NATPARA (Drug) $122.06
- LEQVIO (Drug) $113.00
- Wegovy (Drug) $112.87
- AFREZZA (Drug) $108.30
- Eversense (Device) $105.00
- Repatha (Biological) $88.40
- HUMULIN (Drug) $86.29
- MOUNJARO (Drug) $82.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Charlotte
Dr. Charles Upchurch, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $267,946
Kanakasabai Narasimhan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $99,422
Adam Spitz, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $92,951
Raymond Stadiem, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $47,406
Nisha Nathan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $31,707
Dr. Gary Rolband, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $14,844